Phenixfin Corporation · NASDAQ:PFX
Phenixfin — Medley Capital — Q3 2013 Earnings Presentation
11 slides from Phenixfin's earnings presentation, Jun 30, 2013
Slide 1: Quarter Ended June 30, 2013 Investor Presentation
Quarter Ended June 30, 2013 Investor Presentation
Slide 2: Important Notice
Important Notice This presentation contains “forward looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to risks and uncertainties. Actual outcomes and results could differ materially from those suggested by this presentation du
Slide 3: Financial & Portfolio Highlights
Financial & Portfolio Highlights Financial Highlights Q3-13 Q2-13 Q1-13 Q4-12 Q3-12 Net investment income per share $ 0.37 $ 0.36 $ 0.39 $ 0.36 $ 0.36 Net realized gains (losses) $ - $ 0.01 $ 0.01 $ (0.01) $ - Net unrealized gains (losses) $ (0.27) $ 0.03 $ (0.01) $ 0.02 $ (0.08) Net income per shar
Slide 4: Select Financial & Portfolio Information
Select Financial & Portfolio Information As of and for the Three Months Ended (dollars in millions, except per share data) 6/30/2013 3/31/2013 12/31/2012 9/30/2012 6/30/2012 Net investment income per share - basic & diluted $ 0.37 $ 0.36 $ 0.39 $ 0.36 $ 0.36 Net realized and unrealized gains per sha
Slide 5: Balance Sheet
Balance Sheet (dollars in thousands, except per share data) 6/30/2013 3/31/2013 12/31/2012 9/30/2012 6/30/2012 ASSETS (Unaudited) (Unaudited) (Unaudited) (Audited) (Unaudited) Investments at fair value Non-control/non-affiliate investments $ 677,351 $ 585,282 $ 512,261 $ 393,741 $ 355,035 Affiliate
Slide 6: Portfolio by Issuer as of June 30, 2013
Portfolio by Issuer as of June 30, 2013 RCS Management Corporation & Specialized Medical Services, Inc. ARBOC Specialty Vehicles LLC Ingenio Acquisition LLC Water Capital USA, Inc. 1% 1% 1% 1%1% 1% 1% 4% Harrison Gypsum LLC U.S. Well Services LLC 1% 1% 1% 4% 1% Cenegenics LLC Calloway Laboratories,
Slide 7: Investment Portfolio as of June 30, 2013
Investment Portfolio as of June 30, 2013 Asset Class1 Industry 1% 1% 2% 1% 1% 1% 2% 1% 10% 2% 2% 2% 3% 9% 4% 38% 4% 8% 4% 58% 5% 7% 5% 6% 5% 6% 6% Senior Secured 1st Lien 6% Personal, Food and Miscellaneous Services Business Services Senior Secured 2nd Lien Healthcare, Education and Childcare Person
Slide 8: Performance Overview
Performance Overview Increased quarterly dividend to $0.37 per share for quarter ending 6/30/13 Diversified portfolio with weighted average loan-to-value of 56.4% through MCC’s debt 13.8% portfolio yield as of 6/30/131 FY Q3 2013 gross investment originations of $119.0 million Completed 4.
Slide 9: Performance Since IPO
Performance Since IPO Dividend Growth Portfolio Growth $0.40 $800.0 $0.35 $0.37 $0.36 $0.36 $0.36 $0.36 $700.0 $686 $0.30 $0.31 $600.0 ($ millions) $0.28 $594 $0.25 $0.25 $500.0 $521 $0.20 $0.21 $400.0 $402 $0.15 $363 $0.16 $300.0 $306 $0.10 $249 $200.0 $199 $0.05 $145 $100.0 $105 $85 $0.00 $0.0 Qua
Slide 10: Transaction & Backlog Summary
Transaction & Backlog Summary 1 2 Deal Sector Security $Amount Fixed/Floating Tenor Yield Closed in Q3 FY13 DLR Restaurants LLC Restaurant & Franchise Senior - 1st lien $9.6 Fixed 5.0 years 14.6% DLR Restaurants LLC Restaurant & Franchise Unsecured Debt 0.3 Fixed 5.0 years 14.6% Ingenio Acquisition
Slide 11: Corporate Information
Corporate Information Board of Directors Corporate Officers Research Coverage Corporate Counsel BROOK TAUBE BROOK TAUBE BARCLAYS CAPITAL INC. SUTHERLAND ASBIL & BRENNAN Chairman & Chief Executive Officer Chairman & Chief Executive Officer Mark C. DeVries – (212)-526-9484 LLP Washington, DC ANDREW FE